MaxCyte (MXCT) Competitors $2.12 +0.01 (+0.47%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$2.12 0.00 (-0.24%) As of 07/16/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MXCT vs. IBTA, PRSU, RSKD, NRDS, PSFE, CARS, MEG, MPLN, UXIN, and TRMRShould you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include Ibotta (IBTA), Pursuit Attractions and Hospitality (PRSU), Riskified (RSKD), NerdWallet (NRDS), Paysafe (PSFE), Cars.com (CARS), Montrose Environmental Group (MEG), MultiPlan (MPLN), Uxin (UXIN), and Tremor International (TRMR). These companies are all part of the "business services" industry. MaxCyte vs. Its Competitors Ibotta Pursuit Attractions and Hospitality Riskified NerdWallet Paysafe Cars.com Montrose Environmental Group MultiPlan Uxin Tremor International Ibotta (NYSE:IBTA) and MaxCyte (NASDAQ:MXCT) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation. Does the media prefer IBTA or MXCT? In the previous week, MaxCyte had 4 more articles in the media than Ibotta. MarketBeat recorded 5 mentions for MaxCyte and 1 mentions for Ibotta. MaxCyte's average media sentiment score of 0.97 beat Ibotta's score of 0.00 indicating that MaxCyte is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ibotta 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MaxCyte 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, IBTA or MXCT? Ibotta has a beta of -1.29, suggesting that its stock price is 229% less volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Which has preferable valuation & earnings, IBTA or MXCT? Ibotta has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Ibotta, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIbotta$369.50M2.53$68.74M$1.4824.97MaxCyte$37.68M5.99-$41.06M-$0.40-5.30 Is IBTA or MXCT more profitable? Ibotta has a net margin of 16.24% compared to MaxCyte's net margin of -110.92%. Ibotta's return on equity of 15.04% beat MaxCyte's return on equity.Company Net Margins Return on Equity Return on Assets Ibotta16.24% 15.04% 9.71% MaxCyte -110.92%-19.90%-17.24% Do analysts recommend IBTA or MXCT? Ibotta currently has a consensus price target of $61.60, indicating a potential upside of 66.67%. MaxCyte has a consensus price target of $7.50, indicating a potential upside of 253.77%. Given MaxCyte's stronger consensus rating and higher possible upside, analysts plainly believe MaxCyte is more favorable than Ibotta.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ibotta 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83MaxCyte 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of IBTA or MXCT? 68.8% of MaxCyte shares are held by institutional investors. 16.1% of Ibotta shares are held by company insiders. Comparatively, 3.3% of MaxCyte shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryIbotta beats MaxCyte on 9 of the 16 factors compared between the two stocks. Get MaxCyte News Delivered to You Automatically Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MXCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MXCT vs. The Competition Export to ExcelMetricMaxCyteMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$225.60M$2.90B$5.51B$9.31BDividend YieldN/A2.46%4.25%4.09%P/E Ratio-5.3020.3628.1819.69Price / Sales5.99298.88441.97111.40Price / CashN/A42.3835.5357.53Price / Book1.097.768.235.67Net Income-$41.06M-$55.11M$3.23B$257.51M7 Day Performance-7.02%0.19%-0.58%-0.16%1 Month Performance-1.40%10.80%6.65%9.89%1 Year Performance-57.77%-0.68%27.09%15.08% MaxCyte Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MXCTMaxCyte2.9286 of 5 stars$2.12+0.5%$7.50+253.8%-58.1%$225.60M$37.68M-5.3080IBTAIbotta3.1251 of 5 stars$35.30-3.2%$61.60+74.5%N/A$923.07M$367.25M23.85N/APRSUPursuit Attractions and Hospitality0.7713 of 5 stars$30.15-3.0%$29.67-1.6%N/A$878.19M$366.49M2.451,500News CoverageRSKDRiskified1.1052 of 5 stars$5.14-3.4%$6.03+17.3%-21.1%$857.63M$327.52M-23.36780NRDSNerdWallet3.7391 of 5 stars$11.09-2.0%$15.00+35.3%-33.8%$843.48M$687.60M28.44770News CoveragePSFEPaysafe3.2301 of 5 stars$13.34-0.8%$16.95+27.1%-34.6%$805.50M$1.70B-667.003,300Gap UpCARSCars.com3.7148 of 5 stars$12.09-0.9%$18.30+51.4%-38.5%$775.04M$719.15M17.781,800MEGMontrose Environmental Group2.7646 of 5 stars$22.300.0%$31.80+42.6%-44.0%$773.34M$696.40M-9.613,410MPLNMultiPlan0.1691 of 5 stars$45.43+6.9%$26.25-42.2%N/A$734.65M$930.62M-0.48170UXINUxin1.1986 of 5 stars$3.75-3.8%N/A+156.5%$734.09M$190.40M-18.75810Gap UpTRMRTremor InternationalN/AN/AN/AN/A$726.18M$343.77M-71.43167 Related Companies and Tools Related Companies Ibotta Alternatives Pursuit Attractions and Hospitality Alternatives Riskified Alternatives NerdWallet Alternatives Paysafe Alternatives Cars.com Alternatives Montrose Environmental Group Alternatives MultiPlan Alternatives Uxin Alternatives Tremor International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MXCT) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MXCT Stock Alerts